HEXO

HEXO Corp. (HEXO) | Rumor.io

HEXO

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about HEXO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Apr 9

HEXO Corp. was acquired by Tilray, contributing to the company's growth in cannabis net revenue, which increased 33% to $63.4 million in Q3.
Cannabis gross profit rose to $20.9 million in Q3 from a loss of $32.8 million in the prior year quarter.
The acquisition of HEXO and Truss, as well as growth in Canadian medical, adult-use, wholesale, and international markets, drove Tilray's Q3 results.

Generated by AI

Sentiment

Of the messages about HEXO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	48.8% -9.34
Bearish	—	—	—	51.2% +9.34

Bullish· Apr 11

$HEXO is expected to benefit from its deal with $TLRY, with a potential bargain price of $250M in the medium to long term.
The acquisition of $HEXO by $TLRY is expected to be a positive move for shareholders, with the potential for increased value and distribution of high-THC products globally.
The deal is seen as a strategic move by $TLRY to acquire the best cannabis grower and patents, with the potential for significant upside on value creation.

Bearish· Apr 11

$HEXO's acquisition by $TLRY may lead to near-term and secular challenges for the cannabis industry.
Selling $HEXO now may be a better option than waiting for the stock to potentially decline to an all-time low of $1.11.
The $HEXO-Tilray merger may ultimately result in $HEXO assets being sold for cheap, leading to further stock price declines.

Generated by AI

Topics

Of the messages about HEXO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	—	1.02%
Macro	—	—	—	57.14%
Earnings	—	—	—	0%
Controversies	—	—	—	2.04%
Announcements	—	—	—	39.8%
Analysts	—	—	—	0%

Earnings· Apr 9

HEXO Corp. is mentioned as part of Tilray's acquisitions, contributing to 33% growth in cannabis net revenue to $63.4 million in Q3.
Cannabis gross profit increased to $20.9 million in Q3 from $(32.8) million in the prior year quarter, with adjusted gross profit of $21.1 million.
Tilray's cannabis net revenue growth is attributed to the acquisitions of HEXO and Truss, as well as growth in various business segments.

Analysts· Apr 17

Bank of America initiated HEXO Corp. with a Buy rating and a $10 price target, naming it a "top pick in cannabis."
HEXO Corp. was up 6.22% to $6.32 after Bank of America initiated coverage with a Buy rating and a $10 price target.
Bank of America's $10 price target for HEXO Corp. was higher than its $13 price target for Cronos Group, which the bank initiated with an Underperform rating.

Announcements· Apr 11

HEXO Corp. has agreed to be acquired by Tilray Brands in an all-stock transaction worth $56.0 million US dollars.
The acquisition is expected to create a durable CPG business, with anticipated pro-forma net sales of $215 million and low-cost operations across all Canadian geographies.
HEXO shareholders will receive 0.4352 of a share of Tilray common stock in exchange for each share held, with the deal expected to close after Tilray exercises a secured convertible note worth $173 million.

Technical Analysis· Nov 6

$HEXO has formed a bull flag and is expected to continue higher, with a potential target of $1 and a subsequent gap.
$HEXO has broken above primary channel resistance, which could lead to an explosive move, and is also approaching a breakout at $1.08.
$HEXO has formed a golden cross, but it was reversed, and the stock has moved back below the MA, indicating a potential reversal of the previous bullish trend.

Generated by AI

Community

Of the messages about HEXO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	16.01%
Newcomers	—	—	100%	83.99%

Regulars· Jul 13

A regular investor shares a successful long-term investment strategy in Tilray, noting a 5-year return of $5 from an initial investment of $3,200.
The same investor holds a significant portion of HEXO Corp. shares acquired at $5-6 per share in 2018, before the company went public in the US.
The exchange ratio between HEXO and Tilray is not 1:1, according to a different regular investor, who also notes that the HEXO-to-Tilray exchange is a topic of discussion.

Newcomers· Apr 9

New users are excited about the 33% increase in cannabis net revenue to $63.4 million, reflecting growth in Canadian medical, adult-use, wholesale, and international markets.
Some newcomers are optimistic about the company's prospects, with one user calling Tilray a "Buy" and dismissing short sellers as "Fools".
The acquisition of HEXO Corp. and Truss is seen as a key driver of the company's growth, with one user highlighting the impact of these deals on the company's financial performance.

Generated by AI

Also Discussed

Investors talking about HEXO also mention

#	Name	Attention
1	Aurora Cannabis Inc.ACB	0%-0.01
2	Organigram Global Inc.OGI	0.01%new
3	Village Farms International Inc.VFF	0.01%-0.01
4	Canopy Growth CorporationCGC	0%-0.01
5	Molson Coors Beverage CompanyTAP	0.01%new
6	TrustCo Bank Corp. NYTRST	0%new
7	Cronos Group Inc.CRON	0%+0
8	Tilray Brands Inc.TLRY	0.02%0
9	Amplify Alternative Harvest ETFMJ	0%new
10	Roundhill Cannabis ETFWEED	0%0

HEXO Corp.

Location

Social

What share of all stock conversation is about HEXO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Apr 9

HEXO Corp. was acquired by Tilray, contributing to the company's growth in cannabis net revenue, which increased 33% to $63.4 million in Q3.
Cannabis gross profit rose to $20.9 million in Q3 from a loss of $32.8 million in the prior year quarter.
The acquisition of HEXO and Truss, as well as growth in Canadian medical, adult-use, wholesale, and international markets, drove Tilray's Q3 results.

Generated by AI

Sentiment

Of the messages about HEXO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	48.8% -9.34
Bearish	—	—	—	51.2% +9.34

Bullish· Apr 11

$HEXO is expected to benefit from its deal with $TLRY, with a potential bargain price of $250M in the medium to long term.
The acquisition of $HEXO by $TLRY is expected to be a positive move for shareholders, with the potential for increased value and distribution of high-THC products globally.
The deal is seen as a strategic move by $TLRY to acquire the best cannabis grower and patents, with the potential for significant upside on value creation.

Bearish· Apr 11

$HEXO's acquisition by $TLRY may lead to near-term and secular challenges for the cannabis industry.
Selling $HEXO now may be a better option than waiting for the stock to potentially decline to an all-time low of $1.11.
The $HEXO-Tilray merger may ultimately result in $HEXO assets being sold for cheap, leading to further stock price declines.

Generated by AI

Topics

Of the messages about HEXO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	—	1.02%
Macro	—	—	—	57.14%
Earnings	—	—	—	0%
Controversies	—	—	—	2.04%
Announcements	—	—	—	39.8%
Analysts	—	—	—	0%

Earnings· Apr 9

HEXO Corp. is mentioned as part of Tilray's acquisitions, contributing to 33% growth in cannabis net revenue to $63.4 million in Q3.
Cannabis gross profit increased to $20.9 million in Q3 from $(32.8) million in the prior year quarter, with adjusted gross profit of $21.1 million.
Tilray's cannabis net revenue growth is attributed to the acquisitions of HEXO and Truss, as well as growth in various business segments.

Analysts· Apr 17

Bank of America initiated HEXO Corp. with a Buy rating and a $10 price target, naming it a "top pick in cannabis."
HEXO Corp. was up 6.22% to $6.32 after Bank of America initiated coverage with a Buy rating and a $10 price target.
Bank of America's $10 price target for HEXO Corp. was higher than its $13 price target for Cronos Group, which the bank initiated with an Underperform rating.

Announcements· Apr 11

HEXO Corp. has agreed to be acquired by Tilray Brands in an all-stock transaction worth $56.0 million US dollars.
The acquisition is expected to create a durable CPG business, with anticipated pro-forma net sales of $215 million and low-cost operations across all Canadian geographies.
HEXO shareholders will receive 0.4352 of a share of Tilray common stock in exchange for each share held, with the deal expected to close after Tilray exercises a secured convertible note worth $173 million.

Technical Analysis· Nov 6

$HEXO has formed a bull flag and is expected to continue higher, with a potential target of $1 and a subsequent gap.
$HEXO has broken above primary channel resistance, which could lead to an explosive move, and is also approaching a breakout at $1.08.
$HEXO has formed a golden cross, but it was reversed, and the stock has moved back below the MA, indicating a potential reversal of the previous bullish trend.

Generated by AI

Community

Of the messages about HEXO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	16.01%
Newcomers	—	—	100%	83.99%

Regulars· Jul 13

A regular investor shares a successful long-term investment strategy in Tilray, noting a 5-year return of $5 from an initial investment of $3,200.
The same investor holds a significant portion of HEXO Corp. shares acquired at $5-6 per share in 2018, before the company went public in the US.
The exchange ratio between HEXO and Tilray is not 1:1, according to a different regular investor, who also notes that the HEXO-to-Tilray exchange is a topic of discussion.

Newcomers· Apr 9

New users are excited about the 33% increase in cannabis net revenue to $63.4 million, reflecting growth in Canadian medical, adult-use, wholesale, and international markets.
Some newcomers are optimistic about the company's prospects, with one user calling Tilray a "Buy" and dismissing short sellers as "Fools".
The acquisition of HEXO Corp. and Truss is seen as a key driver of the company's growth, with one user highlighting the impact of these deals on the company's financial performance.

Generated by AI

HEXO

Social

Apr 9

Sentiment

Bullish· Apr 11

Bearish· Apr 11

Topics

Earnings· Apr 9

Analysts· Apr 17

Announcements· Apr 11

Technical Analysis· Nov 6

Community

Regulars· Jul 13

Newcomers· Apr 9

Also Discussed

HEXO Corp.

Company Information

Location

Also Discussed

Social

Apr 9

Sentiment

Bullish· Apr 11

Bearish· Apr 11

Topics

Earnings· Apr 9

Analysts· Apr 17

Announcements· Apr 11

Technical Analysis· Nov 6

Community

Regulars· Jul 13

Newcomers· Apr 9